Carles-Bonnet C, Martinez J, Jarrousse C, Aumelas A, Niel H, Bataille D
INSERM U 376, CHU Arnaud-de-Villeneuve, Montpellier, France.
Peptides. 1996;17(3):557-61. doi: 10.1016/0196-9781(96)00001-0.
Oxyntomodulin inhibits gastric acid secretion via its C-terminal octapeptide. Its minimal active structure was delineated by testing, on histamine-stimulated gastric acid secretion in the conscious rat, the inhibitory effect of octapeptide analogues, shortened either or both on their N- or C- terminus. The octapeptide may be simplified by deleting the two C-terminal amino acids while keeping its efficacy and the slope of the dose-response curve. Suppressing the first N-terminal amino acid dramatically decreased the activity. The nonprotected peptides are metabolized by aminopeptidases and endopeptidases. The increased potency of the N-acetylated forms is related, at least in part, with their protection against aminopeptidases.